Affiliation: Karolinska Institutet
- The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A: implications for toxicity testingAnna Beronius
Institute of Environmental Medicine, Karolinska Institutet, PO Box 210, 171 77 Stockholm, Sweden
Toxicology 311:13-26. 2013..In conclusion, this analysis suggests that DNT-studies conducted according to the standardized OECD TG 426 may overlook sensitive effects of BPA, and possibly other potential endocrine disruptors, especially in female offspring. ..
- Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European UnionAnna Beronius
Karolinska Institutet, Institute of Environmental Medicine, 171 77 Stockholm, Sweden
Regul Toxicol Pharmacol 55:111-22. 2009....
- Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol AAnna Beronius
Karolinska Institutet, Institute of Environmental Medicine, Stockholm, Sweden
Reprod Toxicol 29:132-46. 2010..The results illustrate the impact of differences in risk assessment policy and expert judgment on the risk assessment process and highlight the importance of transparency in this process...
- Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reportingAnna Beronius
Institute of Environmental Medicine, Karolinska Institutet, PO Box 210, 171 77, Stockholm, Sweden Department of Applied Environmental Science, Stockholm University, 106 91, Stockholm, Sweden
J Appl Toxicol 34:607-17. 2014..Together, these resources provide an approach to include all relevant data that may fill information gaps and reduce scientific uncertainty in health risk assessment conclusions, and subsequently also in chemical policy decisions...